Mbbs made easy: (APPROACH TO INTEGRATED MEDICINE)

APPROACH TO RESPIRATORY MEDICINE

algorithmic approach

a deep dive

approach ,diagnosis and management

APPROACH TO PDA

APPROACH TO VSD AND ASD

1️⃣ Definition & classification (standard textbook definitions)2️⃣ Epidemiology & risk factors (include high-risk groups)3️⃣ Etiology & precipitating factors4️⃣ Detailed pathophysiology explained step-by-step (cause → mechanism → clinical effect)5️⃣ Clinical featuresEarly vs lateTypical vs atypicalRed-flag signs6️⃣ Scoring systems / staging / gradingExplain each score, components, interpretation, and clinical relevance7️⃣ InvestigationsBaselineConfirmatoryImaging and laboratory interpretationIndications and contraindications for each investigation8️⃣ Differential diagnosis with key differentiating points9️⃣ Initial approach and emergency management (ABCDE / stabilization if applicable)🔟 Definitive managementMedical management (drug names, doses, duration, contraindications)Surgical / procedural management (indications, timing)Stepwise management algorithms1️⃣1️⃣ Flowchart-based clinical approachFrom first presentation → diagnosis → treatment → follow-up1️⃣2️⃣ ComplicationsEarly and lateDisease-related vs treatment-related1️⃣3️⃣ PrognosisPrognostic factorsPoor outcome predictors1️⃣4️⃣ Prevention & follow-up1️⃣5️⃣ Recent guideline-based recommendations (WHO / CDC / NICE / national guidelines — ONLY if present in provided resources)

SODIUM, POTASSIUM AND CALCIUM

Definition & classification (standard textbook definitions) Epidemiology & risk factors (include high-risk groups) Etiology & precipitating factors Detailed pathophysiology explained step-by-step (cause → mechanism → clinical effect) Clinical featuresEarly vs lateTypical vs atypicalRed-flag signs Scoring systems / staging / gradingExplain each score, components, interpretation, and clinical relevance InvestigationsBaselineConfirmatoryImaging and laboratory interpretationIndications and contraindications for each investigation Differential diagnosis with key differentiating points Initial approach and emergency management (ABCDE / stabilization if applicable) Definitive managementMedical management (drug names, doses, duration, contraindications)Surgical / procedural management (indications, timing)Stepwise management algorithms Flowchart-based clinical approachFrom first presentation → diagnosis → treatment → follow-up ComplicationsEarly and lateDisease-related vs treatment-related PrognosisPrognostic factorsPoor outcome predictors Prevention & follow-up Recent guideline-based recommendations (WHO / CDC / NICE / national guidelines — ONLY if present in provided resources)

APPROACH TO PPH

A DEEP DIVE TO TB TODAY

The management of gastrointestinal (GI) bleeding involves immediate patient stabilization, localization of the bleeding source, and subsequent specific pharmacologic or surgical interventions, depending on the site (upper or lower GI tract) and cause of the hemorrhage.The primary goals of initial therapy are hemodynamic resuscitation and correction of circulatory collapse.Hemodynamic Support: Immediate assessment of airway, breathing, and circulation (ABCs) is mandatory.Vascular Access:Fluid Management: Administer intravenous fluid resuscitation using Normal Saline or balanced crystalloids (e.g., lactated Ringer solution). This practice improves mortality in critically ill patients.Monitoring: Continuous monitoring of vital signs (telemetry, pulse oximetry, BP) and urine output is essential. Hypotension (systolic BP <100 mmHg) or a pulse rate over 100 bpm indicates significant blood volume loss.Positioning: Placing the patient in the Trendelenburg position temporarily can help maintain cerebral blood flow.Blood and Coagulation Management:Transfusion: Blood transfusions are typically performed to maintain haemoglobin (Hb) levels above 7 g/dL (70 g per L) in non-acutely bleeding or minimally bleeding patients. Coagulopathy: Correcting coagulopathy (e.g., administering Vitamin K) and infusing platelets are necessary, especially if thrombocytopenia is symptomatic (platelet count <50,000/µL).Upper GI bleeding originates proximal to the ligament of Treitz. Endoscopy (Esophagogastroduodenoscopy, EGD) is the definitive first-line procedure for diagnosis and intervention, ideally performed within 24 hours of stabilization.Mucosal Bleeding (Non-Variceal, e.g., Ulcers, Erosions): Therapy is directed at neutralising and/or preventing the release of acid.Proton Pump Inhibitors (PPIs): These are the mainstay of therapy, irreversibly blocking the gastric proton pump (H+/K+ ATPase) to significantly reduce acid secretion. Standard intensive dosing involves an IV bolus (e.g., 80 mg) followed by a continuous infusion (e.g., 8 mg/h) for 72 hours.H2 Receptor Antagonists (H2RAs): These block histamine action on parietal cells. IV administration shows mixed, mild benefit in gastric ulcers but no benefit in duodenal ulcers.Sucralfate: This forms a viscous protective barrier over ulcers in an acidic environment (pH<4).Variceal Bleeding (Portal Hypertension): Vasoactive drugs are started immediately after haemodynamic stabilization to reduce splanchnic pressures.Octreotide: Given as an IV bolus (50 µg in adults, or 1 mcg/kg up to 50 mcg maximum) followed by a continuous infusion (e.g., 50 µg/h or 1 mcg/kg/h up to 4 mcg/kg/h maximum) for 2–5 days once bleeding is controlled.Vasopressin/Terlipressin (Glypressin): Terlipressin (2 mg IV every 4 hours until a bleeding-free interval of 24–48 hours is achieved) and Vasopressin (0.002 to 0.005 units/kg per minute for 12 hours, then tapered) are also used.Non-Variceal Management (EGD): Endoscopic therapy is essential for ulcers presenting with active bleeding or high-risk stigmata (like a nonbleeding visible vessel). Modalities include:Variceal Management:Surgical Intervention (Both Types): Surgery is indicated in cases of uncontrolled or recurrent bleeding that fails medical and endoscopic management, or when the patient remains hemodynamically unstable despite aggressive resuscitation (e.g., requiring >6 units of blood transfusion).

APPROACH TO STROKE, DEFINITION, LOCALISATION AND MANAGEMENT [TIME GUIDELINES]

ROLE OF LEVOTHYROXINE AND OTHER TREATMENT OPTIONS

Gold 2024 guidelines of approach to a patient with copd

Approach to diabetes algorithms and management shifts this year

Metformin vs sgl2 inhibitors vs glp1 agonists

definition, types, management, history,approach , take home messages

Approach , Breastfeeding,breastmilk jaundice , physiological vs pathological jaundice , causes , management, phototherapy,dvet

Approach to direct and indirect hyperbilirubinemia

Definition, Symptoms and signs ,Mimics and management

Definition , Sepsis mimics ,Eons, Lons , algorithmic approach and clinical case discussion

Who Definition, Pathogenesis, Protective mechanisms, Management

causes, pathophysiology, differentials, management, findings

NRP, STEPS, INDICATIONS FOR PPV , ET ,CC, ADRENALINE , TIME GUIDELINES

APPROACH, DEFINITION, EVALUATION ,SCORING ,GRADING ANDMANAGEMENT

sepsis, septic shock, qsofa , sirs, introduction, evaluation and management

Causes MechanismsPrognosis Clinical correlations

Overview towards a patient with seizures

Treatment of acute complications of diabetes mellitus

Treatment of asthma according to Gina 2022, and acute exacerbation

Management of ssns, srns, frns, congenital nephrotic syndrome and sdns

Case discussion on nephrotic syndrome and Nephritic Syndrome presentation in both children and adults ....

Approach to hematuria and all the tests performed with the d/d's

Different types of proteinuria and baseline values...

Approach to unstable angina , chronic stable angina ,acs (stemi/nstemi) and followup

Approach to cardiac and non cardiac causes of chest pain

Uploading the most important topics for all the medical students (mbbs) ......